Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy

Blood - Tập 121 - Trang 5154-5157 - 2013
David T. Teachey1,2, Susan R. Rheingold1,2, Shannon L. Maude1,2, Gerhard Zugmaier3, David M. Barrett1,2, Alix E. Seif1,2, Kim E. Nichols1,2, Erica K. Suppa4, Michael Kalos4, Robert A. Berg5,6, Julie C. Fitzgerald5,6, Richard Aplenc1,2, Lia Gore7, Stephan A. Grupp1,2
1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3AMGEN Research (Munich) GmbH, Munich, Germany
4Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Division of Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA
6Department of Anesthesiology and Critical Care Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
7Department of Pediatrics, University of Colorado Cancer Center, Aurora, CO

Tóm tắt

Key Points Cytokine release syndrome caused by T cell-directed therapies may be driven by abnormal macrophage activation and hemophagocytic syndrome. Cytokine-directed therapy can be effective against life-threatening cytokine release syndrome.

Tài liệu tham khảo

Löffler, 2000, A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes., Blood, 95, 2098, 10.1182/blood.V95.6.2098 Bargou, 2008, Tumor regression in cancer patients by very low doses of a T cell-engaging antibody., Science, 321, 974, 10.1126/science.1158545 Topp Topp Topp, 2012, Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL., Blood, 120, 5185, 10.1182/blood-2012-07-441030 Klinger, 2012, Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab., Blood, 119, 6226, 10.1182/blood-2012-01-400515 Tang, 2008, Early diagnostic and prognostic significance of a specific Th1/Th2 cytokine pattern in children with haemophagocytic syndrome., Br J Haematol, 143, 84, 10.1111/j.1365-2141.2008.07298.x Xu Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia., Sci Transl Med, 3, 95ra73, 10.1126/scitranslmed.3002842 Porter, 2011, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia., N Engl J Med, 365, 725, 10.1056/NEJMoa1103849 Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia., N Engl J Med, 368, 1509, 10.1056/NEJMoa1215134 Allen, 2008, Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis., Pediatr Blood Cancer, 50, 1227, 10.1002/pbc.21423 Switala, 2012, Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world., J Pediatr Hematol Oncol, 34, e89, 10.1097/MPH.0b013e31824227b9 Olin, 2008, Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis., Am J Hematol, 83, 747, 10.1002/ajh.21236 Tamura, 2008, Increased serum monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and interleukin-8 concentrations in hemophagocytic lymphohistiocytosis., Pediatr Blood Cancer, 51, 662, 10.1002/pbc.21660 Gore Risma, 2012, Hemophagocytic lymphohistiocytosis: updates and evolving concepts., Curr Opin Pediatr, 24, 9, 10.1097/MOP.0b013e32834ec9c1 Zhizhuo, 2012, Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis., Pediatr Blood Cancer, 58, 410, 10.1002/pbc.23216 Zhang, 2011, Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH., Blood, 118, 5794, 10.1182/blood-2011-07-370148 Trizzino, 2008, Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations., J Med Genet, 45, 15, 10.1136/jmg.2007.052670